Professor, Dermatology, University of Alabama School of Medicine
Dermatology
Dr. Boni E. Elewski, MD
|
|
Give Review
Boni Elewski is an expert in the field of Dermatology. She graduated from The Ohio State University College of Medicine. She received awards:"Fellow (FAAD)". Boni Elewski is also published. She has 55 publications published. The lastest publication: "Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials.' She accepts Medicare.
Publications
- Anti-IL-17 Medications Used in the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review.
- Secukinumab (AIN-457) for the treatment of Psoriasis.
- Secukinumab improves patient-reported Psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials.
- Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque Psoriasis.
- The ABCDEF Rule: Combining the "ABCDE Rule" and the "Ugly Duckling Sign" in an Effort to Improve Patient Self-Screening Examinations.
- Tanning accelerators: prevalence, predictors of use, and adverse effects.
- Tavaborole for the treatment of onychomycosis.
- Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials.
- Treatment of nonmelanoma Skin cancer.
- Azelaic acid foam 15% in the treatment of papulopustular Rosacea: a randomized, double-blind, vehicle-controlled study.
- Treatment of onychomycosis using a submillisecond 1064-nm neodymium:yttrium-aluminum-garnet laser.
- The epidemiology, etiology, and pathophysiology of onychomycosis.
- Diagnosis, clinical implications, and complications of onychomycosis.
- Current and emerging options in the treatment of onychomycosis.
- Promoting and maintaining or restoring healthy Nails: practical recommendations for clinicians and patients.
- Efinaconazole 10% solution in the treatment of toeNail onychomycosis: Two phase III multicenter, randomized, double-blind studies.
- A new classification system for grading the severity of onychomycosis: Onychomycosis Severity Index.
- An Open-label Study of the Safety and Efficacy of Sertaconazole Nitrate in the Treatment of Seborrheic Dermatitis.
- Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US.
- Chemoprevention of nonmelanoma Skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.
- Wong type Dermatomyositis: 20th case reported.
- Long-term safety and efficacy of etanercept in patients with Psoriasis: an open-label study.
- Tinea Capitis in Birmingham: Survey of Elementary School Students.
- Safe and effective treatment of seborrheic Dermatitis.
- Lack of classic histology should not prevent diagnosis of necrolytic acral erythema.
- Results of a national Rosacea patient survey: common issues that concern Rosacea sufferers.
- Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicente...
- The safety and efficacy of high-dose alefacept compared with a loading dose of alefacept in patients with chronic plaque Psoriasis.
- The prevalence of acne in adults 20 years and older.
- In reference to the October 2004 comprehensive overview of Rosacea therapy.
- A novel foam formulation of ketoconazole 2% for the treatment of seborrheic Dermatitis on multiple body regions.
- Onychomycosis: diagnosis and definition of cure.
- New opportunities in preventative dermatology: how far should we go?
- Advances in topical and systemic antiFungals.
- Percutaneous absorption kinetics of topical metronidazole formulations in vitro in the human cadaver Skin model.
- Rosacea trial comparing twice-daily azelaic acid gel 15% with once-daily metronidazole gel 1%.
- Azelaic acid gel 15%: clinical versatility in the treatment of Rosacea.
- Alefacept in the treatment of psoriatic Nail disease: a proof of concept study.
- Clinical diagnosis of common scalp disorders.
- A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis.
- A bipartite interaction between Pseudomonas aeruginosa and fungi in onychomycosis.
- Modification of the Nail Psoriasis Severity Index.
- Epidemiologic surveillance of cutaneous Fungal infection in the United States from 1999 to 2002.
- The use of 40% urea cream in the treatment of moccasin tinea pedis.
- Onychotillomania: 2 case reports.
- A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular Rosacea: results of a randomized trial.
- Tinea capitis in adult women masquerading as bacterial pyoderma.
- Cutaneous anthrax management algorithm.
- Infliximab for the treatment of severe pustular Psoriasis.
- Office practice-based confirmation of onychomycosis: a US nationwide prospective survey.
- Extrafacial and generalized granulomatous periorificial Dermatitis.
- Reactivity to trichophytin antigen in patients with onychomycosis: effect of terbinafine.
- Item-level psychometric properties for a new patient-reported Psoriasis symptom diary.
- New side effect of TNF-alpha inhibitors: morphea.
Schools
Ohio State University College Of Medicine and Public Health
Nc Meml Hospital
Procedures Preformed
- Destruction of Benign Skin Lesion
Conditions Treated
- Acanthosis Nigricans
- Actinic Keratosis
- Athlete's Foot
- Atopic Dermatitis (Eczema)
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- Fellow (FAAD)
Education
-
University of North Carolina Hospitals -
The Ohio State University College of Medicine
Hospital
-
University of Alabama Hospital -
Birmingham Veterans Affairs Medical Center
Drug Facts
| NPI NUMBER | 1437192317 | |
| NPPES Provider LastName | ELEWSKI | |
| NPPES Provider FirstName | BONI | |
| NPPES Provider ZIPCode | 352332110 | |
| NPPES Provider State | AL | |
| Specialty Description | Dermatology | |
| Total Claim Count | 702.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1437192317 |
| Last Name Of The Provider | ELEWSKI |
| First Name Of The Provider | BONI |
| View All |
Similar Doctors
|
|
Dr. Kesha J. Buster, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert M. Pritchett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie C. Harper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rebecca B. Kissel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah L. Hughey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew K. Abele, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Johnathan J. Ledet, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ann M. Hill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rayna M. Dyck, MD |